Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritis

Fig. 2

SHAP plots for baseline important features of trajectories. Important features of group 1 compared to groups 2, 3, and 4 (A), group 2 compared to group 1 (B), group 3 compared to group 1 (C), and group 4 compared to group 1 (D). Abbreviations: ACPA, anti-cyclic citrullinated peptide antibody; ALT, alanine aminotransferase; ANA, anti-nuclear antibody; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CRP, C-reactive protein; DAS28, disease activity score with 28-joint assessment; eGFR, estimated glomerular filtration rate; ESR, erythrocyte sedimentation rate; RF, rheumatoid factor

Back to article page